ATXN3 and Spinocerebellar ataxia type 3: Decreased RORα expression was detected in the nuclei of SCA3 mouse PCs [109,111], and single injection of the RORα/γ agonist SR1078 rescued the behavioral, morphological, and functional deficits in these SCA3 model mice [111].